
Sign up to save your podcasts
Or


This week, Dr. Kahn discusses a patient profile featured in the Wall Street Journal highlighting a rare inherited cholesterol disorder called sitosterolemia. He reviews the case study, explores the condition, and explains why ezetimibe is an excellent prescription choice for lowering both cholesterol and blood plant sterol levels. Additionally, Dr. Kahn shares why he avoids using plant sterols in his clinic.
The episode also covers a variety of short topics, including new research on drugs to lower Lp(a), the protective effects of cocoa and green tea against artery damage from high-fat meals, the benefits of nicotinamide riboside and dietary niacin, and the longevity perks of moderate coffee intake.
Special thanks to igennus.com—use the discount code "DrKahn" to save.
By Dr. Joel Kahn4.6
469469 ratings
This week, Dr. Kahn discusses a patient profile featured in the Wall Street Journal highlighting a rare inherited cholesterol disorder called sitosterolemia. He reviews the case study, explores the condition, and explains why ezetimibe is an excellent prescription choice for lowering both cholesterol and blood plant sterol levels. Additionally, Dr. Kahn shares why he avoids using plant sterols in his clinic.
The episode also covers a variety of short topics, including new research on drugs to lower Lp(a), the protective effects of cocoa and green tea against artery damage from high-fat meals, the benefits of nicotinamide riboside and dietary niacin, and the longevity perks of moderate coffee intake.
Special thanks to igennus.com—use the discount code "DrKahn" to save.

779 Listeners

1,542 Listeners

3,471 Listeners

875 Listeners

716 Listeners

3,415 Listeners

2,638 Listeners

3,470 Listeners

9,194 Listeners

150 Listeners

2,322 Listeners

847 Listeners

300 Listeners

1,246 Listeners

320 Listeners